🔗 Share this article Social Media Influencers Fueling Parallel Trade for Unlicensed Slimming Medication A shadow economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations. Investigational Treatment Gaining Popularity Via Social Media Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also receiving discount codes. Thriving Trade on Social Networks Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting customers to WhatsApp for transactions. Understanding The Experimental Drug This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic. Healthcare Experts Express Worries However, doctors and chemists have warned that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting products of uncertain source. Some experts stated the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro. Legal Position and Enforcement Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012. Some influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment. Platform Response and Content Removal According to the social media company, the service has taken down problematic content and prohibited associated hashtags and query recommendations. The organization stated it was committed to keeping the platform safe and allocating resources in strengthening compliance measures. Digital Marketplace Operations Investigations also found communities with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of members, filled with images of slimming results, positive reviews and detailed instructions for preparing or injecting at home. Within moments of entering one group, a seller posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or previous experience. Product Information and Costs Inside these communities, posts display dark colored packages with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.” Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a injector should last, sellers give conflicting answers ranging from a several days to “depends on your body”. Service Moderation and Security Measures A representative for the messaging service said it regularly moderated dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Medical Professional Warnings “People are administering materials they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U. A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained. Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.” Manufacturer Position A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a company experimental substance not yet approved … may expose patients to potentially serious medical dangers”.